The full benefit of using AI-tools to make predictions and take alternative actions can’t be realised without careful consideration of the accompanying ethical pitfalls, say researchers.
The HHS civil rights division refocuses on the rights of health care providers who have moral objections to treatments such as abortion or sterilization, alarming critics.
A USD $5 million technology prize aims to crack the origin of the genetic code. The Evolution 2.0 Prize was announced at Arizona State University in August 2017. The largest “origin of life” prize to date, it seeks to bridge the gap between chemistry, genomics and modern computing.
“How Can We Anticipate and Respond to Technologies and Information That is Rapidly Changing?” – Josephine Johnston
Josephine Johnston is an expert on the ethical, legal and policy implications of biomedical technologies, particularly as used in human reproduction, psychiatry, genetics, and neuroscience.
In a recent interview, Josiah Zayner admitted, “I didn’t realise the consequences of what would happen” after publicly injecting himself with CRISPR.”
Clinicians can be so focused on fixing problems and saving lives that they often avoid delivering news of a poor prognosis.
Reading the whole genetic blueprint of a fetus long before birth could become a routine procedure thanks to a new blood test.
At a biohacking conference this week, a biotech CEO dropped his pants and injected himself in the thigh with an experimental herpes treatment created by his company, leaving other biohackers worried.
Former drug industry executive, Alex Azar was confirmed by a Senate vote on Wednesday as the next secretary of the Department of Health and Human Services.
To help you plan your visit, or perhaps inspire you to sign up for your free place, we’ve put together a handy guide to this year’s theme, and some of our top picks from the agenda.
Southern Illinois University’s medical school has halted all herpes research, one of its most high-profile projects, amid growing controversy over a researcher’s unauthorized methods offshore and in the U.S.
This year we can expect to see large numbers of CRISPR gene-editing trials, but some are still afraid of this amazing technology.
Sinogene, a biotech company based in Beijing has cloned a gene-edited dog in an attempt to treat cardiovascular disease.